Kindstar Globalgene Technology, Inc. (9960) Stock Statistics & Valuation Metrics

Kindstar Globalgene Technology, Inc. has a market cap or net worth of HK$1.16B. The enterprise value is HK$1.04B.

Kindstar Globalgene Technology, Inc. has 1,041,309,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kindstar Globalgene Technology, Inc.’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -3.44%.

The current PE Ratio of Kindstar Globalgene Technology, Inc. is ―. Kindstar Globalgene Technology, Inc.’s PEG ratio is -6.54.

In the last 12 months, Kindstar Globalgene Technology, Inc. had revenue of 933.57M and earned -58.74M in profits. Earnings per share was -0.06.

In the last 12 months, operating cash flow was 108.48M and capital expenditures -45.87M, giving a free cash flow of 62.61M billion.

Kindstar Globalgene Technology, Inc. pays an annual dividend of HK$0.024, resulting in a dividend yield of 2.02%

Kindstar Globalgene Technology, Inc. upcoming earnings date is Sep 2, 2026, TBA (Confirmed).

Kindstar Globalgene Technology, Inc. as a current ratio of 2.81, with Debt / Equity ratio of 16.04%

In the past 12 months, Kindstar Globalgene Technology, Inc. has paid 14.76M in taxes.

Kindstar Globalgene Technology, Inc. EV to EBITDA ratio is -10.93, with an EV/FCF ratio of 23.98.

Kindstar Globalgene Technology, Inc. has HK$1.56B in cash and marketable securities with HK$438.12M in debt, giving a net cash position of HK$1.12B billion.

Gross margin is 44.07%, with operating margin of -11.89%, and net profit margin of -6.29%.

The average price target for Kindstar Globalgene Technology, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―